Fluticasone
/api/v1/drug/fluticasoneMechanism of action
Sourced from openFDAMechanism-of-action classes: Corticosteroid Hormone Receptor Agonists; Glucocorticoid Receptor Agonists.
Indications
Sourced from openFDA- Uses Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion itchy, watery eyes itchy nose runny nose sneezing
Dosage & administration
Sourced from openFDADirections read the Quick Start Guide for how to: prime the bottle use the spray clean the spray nozzle shake gently before each use use this product only once a day do not use more than directed ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER Week 1- use 2 sprays in each nostril once daily Week 2 through 6 months- use 1 or 2 sprays in each nostril once daily, as needed to treat your symptoms After 6 months of daily use – ask your doctor if you can keep using CHILDREN 4 TO 11 YEARS OF AGE the growth rate of some children may be slower while using this product. Children should use for the shortest amount of time necessary to achieve symptom relief. Talk to your child’s doctor if your child needs to use the spray for longer than two months a year. an adult should supervise use use 1 spray in each nostril once daily CHILDREN UNDER 4 YEARS OF AGE do not use
Warnings & precautions
Sourced from openFDAOnly for use in the nose. Do not spray into your eyes or mouth.
Approval history
Sourced from openFDA- Aug 24, 2000NDANDA021077Glaxo Grp Ltd
- Sep 29, 2000NDANDA020833Glaxo Grp Ltd
- May 14, 2004NDANDA021433Glaxo Grp Ltd
- Jun 8, 2006NDANDA021254Glaxo Grp Ltd
- Apr 27, 2007NDANDA022051Haleon Us Holdings
- May 1, 2012NDANDA202236Mylan Speciality Lp
- May 10, 2013NDANDA204275Glaxo Grp Ltd
- Jul 23, 2014NDANDA205434Haleon Us Holdings
FAERS reports
- 1Dyspnoea32,26612%
- 2Drug Ineffective25,2809.5%
- 3Asthma17,7726.7%
- 4Cough16,7776.3%
- 5Fatigue13,7745.2%
- 6Pneumonia13,6055.1%
- 7Headache12,9154.9%
- 8Off Label Use11,2944.2%
- 9Nausea11,0824.2%
- 10Product Dose Omission Issue11,0504.2%
- 11Pain10,1143.8%
- 12Malaise10,0093.8%
- 13Wheezing9,5993.6%
- 14Diarrhoea9,0733.4%
- 15Dizziness9,0623.4%
Literature
Recent PubMed references pinned to Fluticasone as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- In vitro characterisation of fluticasone propionate and ciclesonide delivered with and without valved holding chambers using cascade impaction and an adult simulated breathing profile.BMJ open respiratory research · 2026 · Csonka LL, Lehtimäki L, Csonka P, et al.PMID 41985982DOI 10.1136/bmjresp-2025-003963
- Development of transdermal nanofilm containing fluticasone propionate: In-vitro, in-vivo correlation.Pakistan journal of pharmaceutical sciences · 2026 · Irfan Siddique MPMID 41879408DOI 10.36721/PJPS.2026.39.5.REG.13335.1
- Fluticasone- vs Budesonide-Based Dual Therapy for COPD.JAMA network open · 2026 · Feldman WB, Ambati VL, Suissa S, et al.PMID 41801200DOI 10.1001/jamanetworkopen.2026.0959
- Single vs Dual Lactose-Polyethylene Glycol 3000 Microcarrier Systems for Pulmonary Salmeterol and Fluticasone Targeted Delivery.Drug design, development and therapy · 2026 · Akram MW, Zainudin BH, Mohamed Tenang ME, et al.PMID 41778147DOI 10.2147/DDDT.S582476
- Azelastine-fluticasone intranasal therapy: A paradigm shift in pediatric allergic rhinitis management. A point of view of the Italian Society of Pediatric Allergy and Immunology.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026 · Marseglia G, Miraglia Del Giudice M, Licari A, et al.PMID 41755501DOI 10.1111/pai.70320
- Efficacy of combining soothing moisturizing repairing cream with glucocorticoids in the treatment of moderate atopic dermatitis in pediatric patients: A prospective observational cohort study.Medicine · 2026 · Guan Z, Lin Y, Wang Y, et al.PMID 41630239DOI 10.1097/MD.0000000000047171
- Investigating the Challenges of Managing Coexisting Subglottic Stenosis and Bronchopulmonary Diseases Medically Using Computational Modeling.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026 · Gao K, Luzum NA, Cohen S, et al.PMID 41474177DOI 10.1002/ohn.70097
- A prospective study comparing the efficacy of Budesonide nasal douching vs. Fluticasone nasal spray in Post FESS patients.The Medical journal of Malaysia · 2025 · Prithviraj SM, Subagar AS, Shree NR, et al.PMID 41456139
Clinical trials
The 10 most recently updated of 832 ClinicalTrials.gov registrations naming Fluticasone as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsActive not recruiting · Phase 3 · Interventional · 2,772 enrolled · Teva Branded Pharmaceutical Products R&D LLCNCT06052267updated 2026-06-11
- BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)Recruiting · Phase 2 · Interventional · 45 enrolled · Dana-Farber Cancer InstituteNCT05922761updated 2026-06-10
- Thread Embedding Acupuncture For Rhinitis AllergyCompleted · Interventional · 64 enrolled · University of Medicine and Pharmacy at Ho Chi Minh CityNCT06858137updated 2026-06-09
- Using a Contact Dermatitis Model With Biologic Medications to Study Skin InflammationActive not recruiting · Phase 2 · Phase 3 · Interventional · 45 enrolled · Wei-Che KoNCT05535738updated 2026-06-09
- A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaRecruiting · Phase 3 · Interventional · 724 enrolled · Teva Branded Pharmaceutical Products R&D LLCNCT06664619updated 2026-06-08
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaRecruiting · Phase 2 · Interventional · 1,147 enrolled · SanofiNCT06676319updated 2026-05-27
- Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma ExacerbationNot yet recruiting · Interventional · 40 enrolled · Juan Carlos CardetNCT07396987updated 2026-05-26
- Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled AsthmaActive not recruiting · Phase 4 · Interventional · 120 enrolled · Regeneron PharmaceuticalsNCT06572228updated 2026-05-22
- Dymista in Chinese AdolescentsNot yet recruiting · Phase 4 · Interventional · 100 enrolled · Viatris Inc.NCT07597473updated 2026-05-19
- Finnish Children´s Protracted CoughRecruiting · Phase 3 · Interventional · 100 enrolled · Tampere University HospitalNCT07582549updated 2026-05-13
Structural analogs
Ranked by 2D fingerprint (Tanimoto) similarity over PubChem structures. Structural proximity only — not a claim of therapeutic equivalence.
Frequently asked questions
- How does Fluticasone work?
- Mechanism-of-action classes: Corticosteroid Hormone Receptor Agonists; Glucocorticoid Receptor Agonists.
- What is Fluticasone used for?
- According to FDA labeling, Fluticasone carries indications including: Uses Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion itchy, watery eyes itchy nose runny nose sneezing. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Fluticasone?
- Fluticasone is classified as Corticosteroids, Corticosteroids, potent (group III), Glucocorticoids, Corticosteroid, Corticosteroid Hormone Receptor Agonists, Glucocorticoid Receptor Agonists, Decreased Capillary Permeability, Decreased Fibroblast Migration, Decreased Glucocorticoid Secretion, Decreased Lysosomal Function, Decreased Polymorphonuclear Leukocyte Migration, Decreased Protein Synthesis.
- What are the brand names for Fluticasone?
- Fluticasone is marketed under brand names including Advair, AirDuo, Aller-Flo, Armonair, Arnuity, Beser, Breo, Clarispray.
fluticasone is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.